13F GuideFiling Basics
What is SEC Form 13F? Ultimate Guide to Institutional Equity Filings
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
AlphaSMO Research GuideRead Guide
CIK: 0001442273
Total reported value
$153.1M
$153.1M
56 檔
40.3%
During the Q1 2026 filing period, Act Capital Management, LLC (CIK: 0001442273) submitted its Form 13F report to the U.S. SEC, disclosing a tracked public equity portfolio valued at $153.1M across 56 reported positions.
Act Capital Management, LLC executed strategic sector rebalancing during Q1 2026, establishing 20 new positions while fully exiting 22 holdings and trimming 12 positions.
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | KRYS | Krystal Biotech Inc | Stock-Healthcare | 12.28% | -1.35% | -0.04% | |
| 2 | CVX | Chevron CORP | Stock-Energy | 12.20% | -4.08% | -4.46% | |
| 3 | XOM | Exxon Mobil CORP | Stock-Energy | 9.33% | -2.32% | -15.15% | |
| 4 | CELC | Celcuity Inc | Stock-Other | 8.22% | -3.97% | +44.56% | |
| 5 | TGTX | Tg Therapeutics Inc | Stock-Healthcare | 6.50% | +2.51% | -7.38% | |
| 6 | ABVX | Abivax Sa-adr | Stock-Other | 6.20% | +2.24% | +10.95% | |
| 7 | AMZN | Amazon.com Inc | Stock-Consumer Disc | 5.40% | -3.39% | +34.15% | |
| 8 | VKTX | Viking Therapeutics Inc | Stock-Healthcare | 5.35% | -0.02% | +1.55% | |
| 9 | ARWR | Arrowhead Pharmaceuticals In | Stock-Healthcare | 4.07% | +1.79% | +10.00% | |
| 10 | NKTR | Nektar Therapeutics | Stock-Other | 4.01% | +0.06% | +38.48% | |
| 11 | CYTK | Cytokinetics Inc | Stock-Healthcare | 3.34% | -0.70% | — | |
| 12 | ALMS | Alumis Inc | Stock-Other | 3.02% | -2.07% | — | |
| 13 | ET | Energy Transfer LP | Stock-Energy | 2.02% | -0.36% | — | |
| 14 | FCX | Freeport-mcmoran Inc | Stock-Materials | 1.78% | -0.44% | — | |
| 15 | AAOI | Applied Optoelectronics Inc | Stock-Tech | 1.72% | -1.14% | — | |
| 16 | XENE | Xenon Pharmaceuticals Inc | Stock-Other | 1.53% | +0.36% | — | |
| 17 | NUVB | Nuvation Bio Inc | Stock-Other | 0.98% | +0.95% | -52.50% | |
| 18 | STAA | Staar Surgical Co | Stock-Other | 0.82% | -0.82% | EXIT | |
| 19 | PRAX | Praxis Precision Medicines I | Stock-Other | 0.68% | -0.09% | +285.71% | |
| 20 | GBTC | Grayscale Bitcoin Trust ETF | ETF-Crypto | 0.64% | -0.18% | -55.23% | |
| 21 | S | Sentinelone Inc -class A | Stock-Tech | 0.55% | -0.55% | EXIT | |
| 22 | LITE | Lumentum Holdings Inc | Stock-Tech | 0.50% | -0.50% | EXIT | |
| 23 | BE | Bloom Energy Corp- A | Stock-Industrials | 0.48% | +1.00% | -65.38% | |
| 24 | CRGY | Crescent Energy Inc-a | Stock-Energy | 0.48% | -0.19% | -26.60% | |
| 25 | KURA | Kura Oncology Inc | Stock-Other | 0.47% | +0.17% | — | |
| 26 | VIR | Vir Biotechnology Inc | Stock-Other | 0.45% | -0.02% | — | |
| 27 | CRCL | Circle Internet Group Inc | Stock-Financials | 0.45% | -0.45% | EXIT | |
| 28 | HCC | Warrior Met Coal Inc | Stock-Materials | 0.44% | -0.12% | -50.00% | |
| 29 | PATH | Uipath Inc - Class A | Stock-Tech | 0.44% | -0.23% | +6.38% | |
| 30 | SRRK | Scholar Rock Holding CORP | Stock-Other | 0.42% | -0.20% | -10.00% | |
| 31 | WGS | Genedx Holdings CORP | Stock-Other | 0.40% | -0.22% | +166.67% | |
| 32 | MU | Micron Technology Inc | Stock-Tech | 0.40% | -0.25% | — | |
| 33 | NVDA | Nvidia CORP | Stock-Tech | 0.38% | -0.38% | EXIT | |
| 34 | REPL | Replimune Group Inc | Stock-Other | 0.37% | -0.37% | EXIT | |
| 35 | RGNX | Regenxbio Inc | Stock-Other | 0.37% | +0.16% | -32.12% | |
| 36 | PALI | Palisade Bio Inc | Stock-Other | 0.35% | +0.07% | +71.67% | |
| 37 | OLMA | Olema Pharmaceuticals Inc | Stock-Other | 0.29% | -0.29% | EXIT | |
| 38 | GLUE | Monte Rosa Therapeutics Inc | Stock-Other | 0.29% | +0.26% | — | |
| 39 | ONDS | Ondas Inc | Stock-Tech | 0.27% | -0.07% | — | |
| 40 | ACOG | Alpha Cognition Inc | Stock-Other | 0.22% | +0.02% | — | |
| 41 | MBX | Mbx Biosciences Inc | Stock-Other | 0.21% | +0.08% | — | |
| 42 | APC | Arko Petroleum CORP | Stock-Other | 0.21% | -0.03% | — | |
| 43 | KYTX | Kyverna Therapeutics Inc | Stock-Other | 0.20% | +0.03% | +19.52% | |
| 44 | RYZ | Ryerson Holding CORP | Stock-Other | 0.19% | -0.01% | — | |
| 45 | ✓ | Stock-Other | 0.16% | -0.02% | — | ||
| 46 | INCY | Incyte CORP | Stock-Healthcare | 0.15% | -0.15% | EXIT | |
| 47 | CAPR | Capricor Therapeutics Inc | Stock-Other | 0.12% | -0.12% | EXIT | |
| 48 | VPG | Vishay Precision Group | Stock-Other | 0.10% | -0.10% | EXIT | |
| 49 | ESPR | Esperion Therapeutics Inc | Stock-Other | 0.10% | -0.10% | EXIT | |
| 50 | AMLX | Amylyx Pharmaceuticals Inc | Stock-Other | 0.10% | -0.10% | EXIT |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | CELC | Celcuity Inc | +3.1% | +44.56% | Add |
| 2 | CVX | Chevron CORP | +2.5% | -4.46% | Trim |
| 3 | NKTR | Nektar Therapeutics | +2.3% | +38.48% | Add |
| 4 | XOM | Exxon Mobil CORP | +1.3% | -15.15% | Trim |
| 5 | AMZN | Amazon.com Inc | +0.8% | +34.15% | Add |
| 6 | PRAX | Praxis Precision Medicines I | +0.5% | +285.71% | Add |
| 7 | ET | Energy Transfer LP | +0.3% | — | Unchanged |
| 8 | KRYS | Krystal Biotech Inc | +0.2% | -0.04% | Trim |
| 9 | WGS | Genedx Holdings CORP | +0.1% | +166.67% | Add |
| 10 | CAPR | Capricor Therapeutics Inc | +0.1% | +233.33% | Add |
| 11 | PALI | Palisade Bio Inc | +0.1% | +71.67% | Add |
| 12 | CRGY | Crescent Energy Inc-a | +0.1% | -26.60% | Trim |
| 13 | ARWR | Arrowhead Pharmaceuticals In | 0% | +10.00% | Add |
| 14 | CYTK | Cytokinetics Inc | 0% | — | Unchanged |
| 15 | TGTX | Tg Therapeutics Inc | 0% | -7.38% | Trim |
| 16 | KYTX | Kyverna Therapeutics Inc | 0% | +19.52% | Add |
| 17 | AMLX | Amylyx Pharmaceuticals Inc | 0% | — | Unchanged |
| 18 | SSYS | Stratasys Ltd. | 0% | — | Unchanged |
| 19 | PDSB | Pds Biotechnology CORP | 0% | — | Unchanged |
| 20 | SRRK | Scholar Rock Holding CORP | 0% | -10.00% | Trim |
| 21 | ✓ | 0% | — | Unchanged | |
| 22 | LSPD | Lightspeed Commerce Inc | 0% | — | Unchanged |
| 23 | ESPR | Esperion Therapeutics Inc | 0% | — | Unchanged |
| 24 | ACOG | Alpha Cognition Inc | -0.1% | — | Unchanged |
| 25 | REPL | Replimune Group Inc | -0.1% | — | Unchanged |
| 26 | KURA | Kura Oncology Inc | -0.2% | — | Unchanged |
| 27 | PATH | Uipath Inc - Class A | -0.2% | +6.38% | Add |
| 28 | STAA | Staar Surgical Co | -0.2% | — | Unchanged |
| 29 | HCC | Warrior Met Coal Inc | -0.4% | -50.00% | Trim |
| 30 | BE | Bloom Energy Corp- A | -0.4% | -65.38% | Trim |
| 31 | VKTX | Viking Therapeutics Inc | -0.5% | +1.55% | Add |
| 32 | RGNX | Regenxbio Inc | -0.6% | -32.12% | Trim |
| 33 | ABVX | Abivax Sa-adr | -0.8% | +10.95% | Add |
| 34 | OLMA | Olema Pharmaceuticals Inc | -0.8% | -53.27% | Trim |
| 35 | GBTC | Grayscale Bitcoin Trust ETF | -1.3% | -55.23% | Trim |
| 36 | NUVB | Nuvation Bio Inc | -3.4% | -52.50% | Trim |
| 37 | ALMS | Alumis Inc | — | NEW | New buy |
| 38 | ✓ | Celcuity Inc Com Mar 20 26 $50 Call (celc) | — | EXIT | Sold out |
| 39 | GPCR | Structure Therapeutics Inc | — | EXIT | Sold out |
| 40 | FIGR | Figure Technology Solut-cl A | — | EXIT | Sold out |
| 41 | SPOT | Spotify Technology S.A. | — | EXIT | Sold out |
| 42 | FCX | Freeport-mcmoran Inc | — | NEW | New buy |
| 43 | AAOI | Applied Optoelectronics Inc | — | NEW | New buy |
| 44 | XENE | Xenon Pharmaceuticals Inc | — | NEW | New buy |
| 45 | IBM | Intl Business Machines CORP | — | EXIT | Sold out |
| 46 | ✓ | — | EXIT | Sold out | |
| 47 | EOG | Eog Resources Inc | — | EXIT | Sold out |
| 48 | SNDK | Sandisk CORP | — | EXIT | Sold out |
| 49 | DVN | Devon Energy CORP | — | EXIT | Sold out |
| 50 | TEVA | Teva Pharmaceutical-sp Adr | — | EXIT | Sold out |
According to official SEC Form 13F filings, Act Capital Management, LLC reported a total U.S. public equity portfolio value of $153.1M across 56 disclosed positions in Q1 2026.
Expert Analysis & Guides for Tracking Wall Street Smart Money Movements
Learn how SEC Form 13F filings work, the $100M threshold, 45-day reporting lag, and how to track top hedge fund holdings.
In terms of portfolio concentration, the top 5 core holdings (including KRYS, CVX, XOM) accounted for 40.3% of total reported equity market value during Q1 2026.
Top New Position Initiated
ALMS
市值: $3.8M
Top Position Liquidated / Trimmed
CELCUITY INC COM MAR 20 26 $50 CALL (CELC)
前期市值: $3.0M
During Q1 2026, Act Capital Management, LLC's top holdings by market value included KRYS (12.3%)、CVX (12.2%)、XOM (9.3%). The largest single position, KRYS, represented 12.3% of total portfolio value.
In Q1 2026, Act Capital Management, LLC made 66 total portfolio adjustments, initiating 20 new buys, adding to 12 positions, trimming 12 holdings, and fully liquidating 22 stocks.
All holding records on this page are fetched directly from the U.S. Securities and Exchange Commission (SEC) EDGAR system (Form 13F-HR). AlphaSMO parses CUSIP identifiers and formats data into Schema.org-compliant datasets.
Understand SEC Form 4 insider disclosures for corporate officers, directors, and 10% owners to track executive transactions.
Understand Rule 144 restricted stock sale notices to spot planned insider liquidations before market sell pressure arrives.
Explore the 5% beneficial ownership threshold, 13D vs 13G filing differences, and recent SEC accelerated deadline rules.
Best practices for analyzing 13F quarterly changes without getting misled by stock splits, options, or market valuation drift.
Learn how AlphaSMO's flagship signal detects high-conviction stocks where 13F hedge funds and corporate insiders buy at the same time.